Your browser doesn't support javascript.
loading
Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD.
Alho, Ana C; Kim, Haesook T; Chammas, Marie J; Reynolds, Carol G; Matos, Tiago R; Forcade, Edouard; Whangbo, Jennifer; Nikiforow, Sarah; Cutler, Corey S; Koreth, John; Ho, Vincent T; Armand, Philippe; Antin, Joseph H; Alyea, Edwin P; Lacerda, Joao F; Soiffer, Robert J; Ritz, Jerome.
Afiliação
  • Alho AC; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal;
  • Kim HT; Department of Biostatistics and Computational Biology, and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA; and Harvard Chan School of Public Health, Boston, MA.
  • Chammas MJ; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;
  • Reynolds CG; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;
  • Matos TR; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA;
  • Forcade E; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA;
  • Whangbo J; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA;
  • Nikiforow S; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA;
  • Cutler CS; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA;
  • Koreth J; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA;
  • Ho VT; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA;
  • Armand P; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA;
  • Antin JH; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA;
  • Alyea EP; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA;
  • Lacerda JF; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal;
  • Soiffer RJ; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA;
  • Ritz J; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA; Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA; and.
Blood ; 127(5): 646-57, 2016 Feb 04.
Article em En | MEDLINE | ID: mdl-26670634
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Linfócitos T Reguladores / Transplante de Células-Tronco Hematopoéticas / Linfócitos T CD8-Positivos / Doença Enxerto-Hospedeiro Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Linfócitos T Reguladores / Transplante de Células-Tronco Hematopoéticas / Linfócitos T CD8-Positivos / Doença Enxerto-Hospedeiro Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2016 Tipo de documento: Article